Intrinsic value of Boston Trust Walden SMID Cap Fund (WASMX)

Live fair value data for Boston Trust Walden SMID Cap Fund (WASMX) is currently unavailable. Please check again shortly.

Fallback estimate (fair value API unavailable)

Intrinsic Value (Fair Value): Unlock fair value

Upside: +53.0%

Margin of Safety: +34.6%

Current Price: $80.00

Valuation: Undervalued

Confidence: 9.5/10

Visual Bar

Market Price $80.00Intrinsic Value Locked

Undervalued ✅Fair Value ⚖️Overvalued ❌

This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.

Is Boston Trust Walden SMID Cap Fund (WASMX) undervalued or overvalued?

Based on the current model output, Boston Trust Walden SMID Cap Fund appears to be undervalued with a upside of 53.00%.

Fair value vs market price — Boston Trust Walden SMID Cap Fund (WASMX)

Unlock premium access to view the live fair value comparison against current market price for WASMX.

Unlock Fair Value

Frequently Asked Questions - WASMX

How is WASMX intrinsic value estimated?

We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for WASMX.

Is WASMX undervalued or overvalued right now?

WASMX is currently shown as undervalued based on the difference between market price and intrinsic value.

How should I use the confidence score?

The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.

Related companies — intrinsic value

Peers for WASMX: open their intrinsic value pages.

Explore Other Stocks

AAPL TSLA NVDA MSFT